Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report)’s share price reached a new 52-week high on Wednesday following a better than expected earnings announcement. Get Bio-Rad Laboratories alerts:Bio-Rad Laboratories News RoundupHere are the key news stories impacting Bio-Rad Laboratories this week:Positive Sentiment: Q2 earnings topped expectations. Bio-Rad Laboratories Beats Q2 Earnings EstimatesBio-Rad reported adjusted earnings of $2.62 per share, well above the $1.75 consensus estimate cited by MarketBeat and the $2.34 estimate from Zacks. Bio-Rad Laboratories Earnings ReportQuarterly revenue was $651 million, above the approximately $624 million analyst estimate, while operating cash flow reached $98.7 million. Featured StoriesReceive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.